Enrestec Balance Sheet Health
Financial Health criteria checks 2/6
Enrestec has a total shareholder equity of NT$1.5B and total debt of NT$695.3M, which brings its debt-to-equity ratio to 47.7%. Its total assets and total liabilities are NT$2.3B and NT$803.6M respectively. Enrestec's EBIT is NT$30.8M making its interest coverage ratio 2.4. It has cash and short-term investments of NT$133.1M.
Key information
47.7%
Debt to equity ratio
NT$695.29m
Debt
Interest coverage ratio | 2.4x |
Cash | NT$133.13m |
Equity | NT$1.46b |
Total liabilities | NT$803.57m |
Total assets | NT$2.26b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 7507's short term assets (NT$282.8M) exceed its short term liabilities (NT$258.9M).
Long Term Liabilities: 7507's short term assets (NT$282.8M) do not cover its long term liabilities (NT$544.7M).
Debt to Equity History and Analysis
Debt Level: 7507's net debt to equity ratio (38.6%) is considered satisfactory.
Reducing Debt: 7507's debt to equity ratio has increased from 32.1% to 47.7% over the past 5 years.
Debt Coverage: 7507's debt is not well covered by operating cash flow (14%).
Interest Coverage: 7507's interest payments on its debt are not well covered by EBIT (2.4x coverage).